Mosapride Citrate (Shandong New Time Pharmaceutical)

枸橼酸莫沙必利 (山东新时代药业有限公司)

Report date: 2025/03/07 20:00:40

Base Information

Drug NameMosapride Citrate (Shandong New Time Pharmaceutical)
Drug Alias NameMosapride Citrate Injection
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonists
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A